Korean Journal of Family Practice

Table. 4.

Odds ratios (95% confidence interval) for MAFLD according to MMD groups in males and females^a

Variable	Group 1 (n=362)	Group 2 (n=1,163)	Group 3 (n=1,108)	Group 4 (n=1,116)
Male
Unadjusted	1	2.47 (1.39–4.37)	2.91 (1.65–5.13)	2.42 (1.36–4.29)
Adjusted^b	1	2.74 (1.53–4.90)	4.30 (2.40–7.70)	9.15 (4.96–16.88)

	Group 1 (n=440)	Group 2 (n=1,873)	Group 3 (n=1,758)	Group 4 (n=1,725)
Female
Unadusted	1	1.30 (0.74–2.27)	1.12 (0.63–1.98)	0.35 (0.18–0.68)
Adjusted^b	1	1.79 (1.00–3.20)	2.56 (1.40–4.68)	1.91 (0.92–3.95)

MAFLD, metabolic dysfunction-associated fatty liver disease; MMD, muscle mass deficit; ALT, alanine aminotransferase.

^aIn males, Group 1 is defined as MMD=0 kg; Group 2 is defined as 0 kg5.4 kg. In females, Group 1 is defined as MMD=0 kg; Group 2 is defined as 0 kg4.8 kg. ^bAdjusted for age, body mass index, ALT, current smoking, alcohol consumption, and regular exercise.

Korean J Fam Pract 2023;13:171~178 https://doi.org/10.21215/kjfp.2023.13.3.171